Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,545.5
-13.6 (-0.53%)

 

  • STI Straits Times Index
    2,545.5
    -13.6 (-0.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,578.1
    -10.4 (-0.66%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,531.6
    -399.0 (-1.60%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,354.0
    -32.4 (-0.96%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,329.9
    -88.2 (-0.39%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,143.9
    -34.4 (-0.66%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,268.2M
  • Value: 1,358.8M
  • Rise: 113
  • Fall: 217
  • Unch: 478

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.008+0.001
ThaiBev0.605-0.020
Genting Sing0.680-0.030
Asian Healthcare0.285+0.050
Vicplas Intl0.390+0.065
ISDN0.395+0.030
AsiaMedic0.023+0.002
CNMC Goldmine0.360+0.015
Rex Intl0.184-0.003
Medtecs Intl0.970-0.030

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 07 Aug 2020 17:14
Last (SGD): 0.970 Change: -0.030 High: 1.020 Remarks: -
Change (%): -3.00 Low: 0.965
Open 1.010 Yesterday's Close 1.000
Buy Price 0.970 Sell Price 0.975
Buy Volume ('000) 625.4 Sell Volume ('000) 11.0
Cumulative Volume ('000) 24,321.0 Cumulative Value 23,899,188
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.00285 Trailing EPS (SGD) e 0.00285 NAV (SGD) b 0.1559
PE a 340.351 Trailing PE f 340.529 Price / NAV b 6.2219
Dividend (SGD) d - Cash In Hand (SGD) g 0.0075 Issued & Paid-up Shares c 549,411,000
Dividend Yield (%) d - Price / Cash In Hand g 129.333 Treasury Shares h -
Beta - 75 Daysi 0.656 R-Squared - 75 Days(%)i 0.94 Market Cap (M) 532.929
Beta - 500 Daysi -0.227 R-Squared - 500 Days (%)i 0.05 Enterprise Value (M) 585.629
Piotroski F Score 7 Exchange Code 546 Par Value ( USD ) n.a.
52 Weeks Volatility (%) 139.2143 6-Month VWAP 0.314 Free Float (%) -
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 16 Apr 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 532.929 340.351 340.529 6.2219 -
Industry Medical & Biotechnology SGX 944.015 20.913 19.142 1.3020 2.032
Medical Specialties SGX 4,408.757 225.591 126.517 20.5664 0.240
Index FTSE ST Catalist Index SGX 74.895 30.063 88.683 0.9384 1.875
Local Peer Top Glove SGX 25,114.437 206.078 117.261 22.8874 0.251
Local Peer UG Healthcare SGX 639.263 255.086 314.289 15.0508 0.078
Local Peer Biolidics SGX 105.445 - - 9.6890 -
Local Peer Yunnan Energy SGX 43.794 - - 0.9014 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 180,151.427 49.141 58.624 5.8915 1.291
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 164,458.215 44.496 44.376 5.5049 0.184
Global Peer DANAHER CORP NYSE 145,918.337 58.630 49.953 4.4226 0.324
Global Peer MEDTRONIC PLC NYSE 129,743.949 27.092 27.092 2.5572 2.233
Global Peer INTUITIVE SURGICAL INC NASDAQ 80,894.223 58.649 71.210 9.2551 -
Global Peer BECTON DICKINSON & CO NYSE 73,593.983 68.017 148.076 - 1.139
Global Peer STRYKER CORP NYSE 70,835.536 34.007 44.245 5.5540 1.129
Global Peer BOSTON SCIENTIFIC CORP NYSE 54,208.086 11.534 13.620 - -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 48,128.971 45.973 64.724 12.5364 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 47,912.277 36.682 43.002 3.8951 1.704
Other Global Peers DEXCOM INC (NASDAQ), BAXTER INTERNATIONAL INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), ALCON AG (NYSE), AGILENT TECHNOLOGIES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), TOPGLOV (Bursa), HOLOGIC INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), HARTA (Bursa), COOPER COS INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), PERKINELMER INC (NYSE), STERIS PLC (NYSE), WATERS CORP (NYSE), MASIMO CORPORATION (NASDAQ), WEIGAO GROUP (HKEx), QUIDEL CORP (NASDAQ), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), COCHLEAR LTD (ASX), MICROPORT (HKEx), PENUMBRA INC (NYSE), NOVOCURE LTD (NASDAQ), SUPERMX (Bursa), BRUKER CORPORATION (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), NEVRO CORP (NYSE), KANGJI MEDICAL (HKEx), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), VENUS MEDTECH-B (HKEx), WRIGHT MEDICAL GROUP NV (NASDAQ), HAEMONETICS CORP (NYSE), ICU MEDICAL INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), INARI MEDICAL INC (NASDAQ), AK MEDICAL (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), PEIJIA-B (HKEx), CONMED CORP (NYSE), EBOS GROUP (ASX), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), ATRICURE INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), CAREDX INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), AVANOS MEDICAL INC (NYSE), BIOTELEMETRY INC (NASDAQ), NANOSONICS LIMITED (ASX), CIRC (HKEx), MESA LABORATORIES INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), KDL MEDICAL (HKEx), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), INMODE LTD (NASDAQ), LIFETECH SCI (HKEx), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), VAPOTHERM INC (NYSE), ACCELERATE DIAGNOSTICS INC (NASDAQ), CRYOLIFE INC (NYSE), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), VERICEL CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), NATUS MEDICAL INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ZYNEX INC (NASDAQ), SI BONE INC (NASDAQ), QUOTIENT LTD (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), AVITA THERAPEUTICS INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), VIEWRAY INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), YESTAR HEALTH (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), PW MEDTECH (HKEx), RETRACTABLE TECHNOLOGIES INC (NYSE American), AROA BIOSURGERY LTD (ASX), GOLDEN MEDITECH (HKEx), UTAH MEDICAL PRODUCTS (NASDAQ), STEREOTAXIS INC (NYSE American), PROFOUND MED CORP (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), PULSE BIOSCIENCES INC (NASDAQ), ALPHA PRO TECH (NYSE American), IRADIMED CORP (NASDAQ), CORMEDIX INC (NYSE American), CUTERA INC (NASDAQ), MISONIX INC (NASDAQ), INVACARE CORP (NYSE), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ACCURAY INCORPORATED (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), DERMTECH INC (NASDAQ), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), VINCENT MED (HKEx), LKL (Bursa), FONAR CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), MODERN DENTAL (HKEx), SOLITON INC (NASDAQ), ELECTROMED INC (NYSE American), SOLENO THERAPEUTICS INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), NEMAURA MEDICAL INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), BIOMERICA INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), ELECTROCORE INC (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), CYCLOPHARM LIMITED (ASX), RESAPP HEALTH LIMITED (ASX), SOMNOMED LIMITED (ASX), ZOSANO PHARMA CORP (NASDAQ), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), YUNNAN ENERGY (HKEx), DAXOR CORP (NYSE American), NEURONETICS INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), DIMERIX LTD (ASX), RESPIRI LTD (ASX), MILESTONE SCIENTIFIC INC (NYSE American), CLEARPOINT NEURO INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), IMPEDIMED LIMITED (ASX), SDI LTD (ASX), COMPUMEDICS (ASX), ONCOCYTE CORP (NYSE American), CONFORMIS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), KELFRED (HKEx), RESONANCE HEALTH LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), MICRO-X LTD (ASX), STRATA SKIN SCIENCES INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), NEOVASC INC (NASDAQ), IMMUCELL CORP (NASDAQ), AVINGER INC (NASDAQ), CELSION CORPORATION (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ATOSSA THERAPEUTICS INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), CHF SOLUTIONS INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), LBT INNOVATIONS LTD (ASX), OVENTUS MEDICAL LTD (ASX), NEUROTROPE INC (NASDAQ), IRIDEX CORP (NASDAQ), CARDIEX LTD (ASX), METALICITY LIMITED (ASX), AETHLON MEDICAL INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), LIFE HEALTHCARE (HKEx), RA MEDICAL SYSTEMS INC (NYSE), PREDICTIVE ONCOLOGY INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), USCOM LTD (ASX), BIOLASE INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), ALLEGRA ORTHOPAEDICS LIMITED (ASX), OPTISCAN IMAGING (ASX), TENAX THERAPEUTICS INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), CYANOTECH CORP (NASDAQ), NANOVIBRONIX INC (NASDAQ), ADHERIUM LIMITED (ASX), DYNATRONICS CORP (NASDAQ), DIGIRAD CORP (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), STHAI (SET), VIVEVE MEDICAL INC (NASDAQ), NEUROMETRIX INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ANALYTICA (ASX), OBALON THERAPEUTICS INC (NASDAQ), HUAKANG BIOMED (HKEx), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.070
+7.78 %
10 Days -+0.220
+29.33 %
20 Days -+0.100
+11.49 %
Medium Term Return 3 Months -+0.794
+451.14 %
6 Months -+0.867
+841.75 %
1 Year -+0.942
+3364.29 %
Long Term Return 2 Years -+0.929
+2265.85 %
3 Years -+0.920
+1840.00 %
5 Years -+0.920
+1840.00 %
Annualised Return Annualised --
+80.95 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.026 - 1.050 Change From 1 Year Low +0.944 % Change From 1 Year Low (%) +3630.77
Change From 1 Year High -0.080 % Change From 1 Year High (%) -7.62
2 Years Range 0.022 - 1.050 Change From 2 Years Low +0.948 % Change From 2 Years Low (%) +4309.09
Change From 2 Years High -0.080 % Change From 2 Years High (%) -7.62
5 Years Range 0.022 - 1.050 Change From 5 Years Low +0.948 % Change From 5 Years Low (%) +4309.09
Change From 5 Years High -0.080 % Change From 5 Years High (%) -7.62
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

IPO Performance

Listing Date 06 Oct 1999 Full Subscription Rate (x) 10.99
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) 25.98
IPO Price (SGD) a 0.251 First Day Close (SGD) a 0.334 First Week Close (SGD) a 0.328
Current vs IPO Price (%) +286.45 First Day Gain (%) +33.07 First Week Gain (%) +30.68
Notes:
  1. Adjusted for the following: Bonus issue 1 for 5 on 29/04/2004

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(5.04 MB)
Annual Report 2018 Dec 2018 Part 1(3.96 MB)
Annual Report 2017 Dec 2017 Part 1(3.57 MB)
Part 2(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Annual Report 2015 Dec 2015 Part 1(1.52 MB)
Annual Report 2014 Dec 2014 Part 1(4.00 MB)
Annual Report 2013 Dec 2013 Part 1(3.85 MB)
Annual Report 2012 Dec 2012 Part 1(3.68 MB)
Annual Report 2011 Dec 2011 Part 1(6.92 MB)
Annual Report 2010 Dec 2010 Part 1(3.56 MB)
Annual Report 2009 Dec 2009 Part 1(2.70 MB)
Annual Report 2008 Dec 2008 Part 1(1.48 MB)
Annual Report 2007 Dec 2007 Part 1(3.26 MB)
Part 2(0.02 MB)
Annual Report 2006 Dec 2006 Part 1(7.72 MB)
Annual Report 2005 Dec 2005 Part 1(23.76 MB)
IPO Prospectus
IPO Prospectus 1999 Oct 1999 Part 1(0.12 MB)
Part 2(0.39 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
07 Aug 2020 1.010 1.020 0.965 0.970 24,321,000 0.9827
06 Aug 2020 0.990 1.030 0.985 1.000 25,749,000 1.0018
05 Aug 2020 0.990 1.050 0.980 1.010 36,902,100 1.0194
04 Aug 2020 1.030 1.040 0.945 0.985 45,987,100 0.9934
03 Aug 2020 0.945 1.020 0.945 1.010 76,752,100 0.9803
30 Jul 2020 0.865 0.920 0.850 0.900 50,244,400 0.8949
29 Jul 2020 0.885 0.890 0.840 0.850 34,157,200 0.8649
28 Jul 2020 0.775 0.880 0.770 0.875 84,793,100 0.8214
27 Jul 2020 0.755 0.775 0.745 0.765 16,102,200 0.7614
24 Jul 2020 0.775 0.775 0.740 0.750 12,283,800 0.7554
23 Jul 2020 0.750 0.775 0.745 0.760 32,044,300 0.7644
22 Jul 2020 0.765 0.765 0.725 0.730 17,919,500 0.7442
21 Jul 2020 0.730 0.790 0.690 0.745 66,748,200 0.7493
20 Jul 2020 0.665 0.740 0.645 0.735 93,436,700 0.6985
17 Jul 2020 0.510 0.625 0.495 0.625 68,493,300 0.5693
16 Jul 2020 0.665 0.675 0.520 0.520 39,808,600 0.5879
15 Jul 2020 0.685 0.695 0.595 0.645 34,022,600 0.6572
14 Jul 2020 0.650 0.720 0.605 0.635 57,499,900 0.6502
13 Jul 2020 0.935 0.965 0.560 0.680 136,617,600 0.7854
09 Jul 2020 0.855 0.910 0.845 0.870 79,376,600 0.8785
08 Jul 2020 0.735 0.820 0.710 0.820 77,174,700 0.7600
07 Jul 2020 0.685 0.770 0.650 0.705 109,380,300 0.7020
Summary
Current 2 Weeks
(24 Jul 2020 to 07 Aug 2020)
0.775 1.050 0.740 0.970 407,292,000 -
Previous 2 Weeks
(09 Jul 2020 to 23 Jul 2020)
0.855 1.050 0.740 0.760 625,967,300 -
4 Weeks from
(11 Jun 2020 to 08 Jul 2020)
0.275 1.050 0.260 0.820 1,118,632,700 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.